After extensive independent testing at two Global Virus Network Centers of Excellence in Australia and Belgium, the group has confirmed that a BIOPROTECT formulation has been proven to eradicate SARS-CoV-2 on surfaces and provide residual surface protection against the virus for more than six weeks.
As individuals begin to return to travel with an increased focus on health and wellness, we are proud to offer a private jet solution that provides travelers both peace of mind and a guaranteed standard of safety
Jamie Walker, President & CEO, Jet Linx Aviation
Jet Linx has also installed BIOPROTECT Hand Purifier dispensers in all its private terminals and offers BIOPROTECT Hand Purifier inflight on its fleet of over 100 private jets.
“The results of the tests conducted by the Doherty and the Rega Institutes clearly demonstrate that BIOPROTECT eradicates SARS-CoV-2 on surfaces and provides continuous residual antimicrobial protection for an extended period of time,” said Dr. Christian Bréchot, President of the GVN.
He added, “It is clear that effective antimicrobials will be extremely important in containing the COVID-19 pandemic, given the time it will take to implement mass vaccination and fully develop novel therapies.”
Brechot claimed, “In this context, we are not aware of any microbicide surface treatment that continuously prohibits the growth and surface transmissibility of SARS-CoV-2 for an extended period of time.”
He said, “This represents a significant breakthrough in inhibiting the spread of COVID-19 by preventing surfaces from being contaminated by the virus and stopping the spread of the virus through contact with contaminated surfaces.”
Jamie Walker, President and CEO of Jet Linx added, “As individuals begin to return to travel with an increased focus on health and wellness, we are proud to offer a private jet solution that provides travelers both peace of mind and a guaranteed standard of safety.”